Edition:
United Kingdom

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

106.67USD
18 Jan 2018
Change (% chg)

$-0.10 (-0.09%)
Prev Close
$106.77
Open
$106.76
Day's High
$107.35
Day's Low
$105.91
Volume
80,602
Avg. Vol
94,940
52-wk High
$119.03
52-wk Low
$77.65

Chart for

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 0.93
Market Cap(Mil.): $5,230.56
Shares Outstanding(Mil.): 47.59
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 85.70 16.58
EPS (TTM): -- -- --
ROI: -- 3.19 10.60
ROE: -- 4.52 14.19

BRIEF-Charles River Laboratories International Board Size Increases From Ten To Eleven​

Jan 16 Charles River Laboratories International Inc:

16 Jan 2018

BRIEF-Charles River Laboratories Acquires KWS Biotest for GBP 15 Mln

Jan 11 Charles River Laboratories International Inc:

11 Jan 2018

BRIEF-Charles River Laboratories reports Q3 non-GAAP EPS of $1.30

Nov 9 Charles River Laboratories International Inc:

09 Nov 2017

BRIEF-Charles River announces expansion of in vitro oncology services

Oct 26 Charles River Laboratories International Inc

26 Oct 2017

BRIEF-Charles River Laboratories posts Q2 adj. earnings $1.29/shr

Aug 9 Charles River Laboratories International Inc

09 Aug 2017

BRIEF-Charles River Laboratories acquires Brains On-Line

Aug 7 Charles River Laboratories International Inc

07 Aug 2017

Earnings vs. Estimates